Showing 151-160 of 209 results for "".
Can Dupilumab Improve Keloid Scarring?
https://practicaldermatology.com/topics/skin-of-color/can-dupilumab-improve-keloid-scarring/23820/Lupus erythematosus tumidus vs Jessner's lymphocytic infiltrate of the Skin
https://practicaldermatology.com/topics/general-topics/lupus-erythematosus-tumidus-vs-jessners-lymphocytic-infiltrate-of-the-skin/21686/A systematic comparison of clinical and histologic characteristics.Optimizing Dermatology Office Visits With Children and Families
https://practicaldermatology.com/topics/practice-management/optimizing-dermatology-office-visits-with-children-and-families/23897/Different ages call for different approaches when seeing pediatric patients.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-27/23585/Financial Literacy of Dermatology Residents: The Need for a Curriculum
https://practicaldermatology.com/youngmd-connect/resident-resource-center/financial-literacy-of-dermatology-residents-the-need-for-a-curriculum/23237/Education on financial matters is sorely lacking in medical training.What Does Efficacy Cost? Evidence for Relative Cost-Effectiveness of Biologic Therapies for Psoriasis
https://practicaldermatology.com/topics/psoriasis/what-does-efficacy-cost-evidence-for-relative-cost-effectiveness-of-biologic-therapies-for-psoriasis/23128/Despite high costs, evidence suggests that biologics are cost-effective options for moderate to severe psoriasis because of their efficacy.Digital Photomapping (DPM) in Mohs
https://practicaldermatology.com/topics/general-topics/digital-photomapping-dpm-in-mohs/20682/When to Consider Therapeutic Switching in Plaque Psoriasis: Best Practices for Nurse Practitioners, Physician Assistants, and Physicians
https://practicaldermatology.com/topics/psoriasis/when-to-consider-therapeutic-switching-in-plaque-psoriasis-best-practices-for-nurse-practitioners-physician-assistants-and-physicians/21054/What to know about patient experiences and the proper approaches to modifying treatment regimens.Revisiting Cyclosporine in the Age of Biologics: Update on Efficacy and Mechanism of Action
https://practicaldermatology.com/topics/general-topics/revisiting-cyclosporine-in-the-age-of-biologics-update-on-efficacy-and-mechanism-of-action/21937/Increased understanding of the immunologic basis of psoriasis supports the role of cyclosporine in patient management.Psoriasis Treatment in 2025: More Options, Better Outcomes
https://practicaldermatology.com/issues/august-2025/psoriasis-treatment-in-2025-more-options-better-outcomes/36706/We have better drugs to treat psoriasis than almost any other dermatologic disease state. For patients, it is an excellent time to have psoriasis.